文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：巨噬细胞介导的蛋黄脂质递送系统对乳腺癌的增强抗肿瘤疗效[更正]。

Erratum: Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer [Corrigendum].

出版信息

Int J Nanomedicine. 2021 Jan 12;16:237-238. doi: 10.2147/IJN.S300697. eCollection 2021.

DOI:10.2147/IJN.S300697

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7811464/

Abstract

[This corrects the article DOI: 10.2147/IJN.S271310.].

摘要

[本文更正了文章的数字对象标识符：10.2147/IJN.S271310。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d4c/7811464/2bd8f7444479/IJN-16-237-g0001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d4c/7811464/2bd8f7444479/IJN-16-237-g0001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d4c/7811464/2bd8f7444479/IJN-16-237-g0001.jpg

相似文献

1

Erratum: Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer [Corrigendum].勘误：巨噬细胞介导的蛋黄脂质递送系统对乳腺癌的增强抗肿瘤疗效[更正]。

Int J Nanomedicine. 2021 Jan 12;16:237-238. doi: 10.2147/IJN.S300697. eCollection 2021.

2

Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer.增强型巨噬细胞介导的卵黄脂质递药系统对乳腺癌的抗肿瘤疗效。

Int J Nanomedicine. 2020 Dec 10;15:10075-10084. doi: 10.2147/IJN.S271310. eCollection 2020.

3

Erratum: Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum].勘误：16型人乳头瘤病毒E7肽与CpG寡脱氧核苷酸佐剂的甘露糖修饰脂质体共递送增强对小鼠体内已形成的大型TC-1移植瘤的抗肿瘤活性[勘误]

Int J Nanomedicine. 2021 Jan 15;16:469-470. doi: 10.2147/IJN.S301485. eCollection 2021.

4

Erratum: Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum].勘误：用于治疗转移性乳腺癌的亚细胞器靶向纳米结构脂质载体[勘误说明]

Int J Nanomedicine. 2023 Aug 3;18:4447-4448. doi: 10.2147/IJN.S431592. eCollection 2023.

5

Erratum: Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC [Corrigendum].勘误：肿瘤微环境响应性脂质体同时包封生物药和化疗药以增强非小细胞肺癌的抗肿瘤疗效[更正]

Int J Nanomedicine. 2021 Dec 14;16:8067-8068. doi: 10.2147/IJN.S353086. eCollection 2021.

6

Erratum: Bone Regeneration Revolution: Pulsed Electromagnetic Field Modulates Macrophage-Derived Exosomes to Attenuate Osteoclastogenesis [Corrigendum].勘误：骨再生革命：脉冲电磁场调节巨噬细胞衍生的外泌体以减弱破骨细胞生成[勘误]

Int J Nanomedicine. 2024 Sep 12;19:9371-9372. doi: 10.2147/IJN.S495348. eCollection 2024.

7

Erratum: Folic Acid-Targeted Disulfide-Based Cross-Linking Micelle for Enhanced Drug Encapsulation Stability and Site-Specific Drug Delivery Against Tumors [Corrigendum].勘误：用于增强药物包封稳定性和肿瘤靶向性药物递送的叶酸靶向二硫键交联胶束 [勘误]。

Int J Nanomedicine. 2021 Nov 16;16:7683-7684. doi: 10.2147/IJN.S347786. eCollection 2021.

8

Erratum: Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum].勘误：脂质包被的中空介孔二氧化硅纳米粒子递送miR-375和阿霉素以克服肝细胞癌中的多药耐药性[勘误说明]

Int J Nanomedicine. 2019 Nov 6;14:8753-8754. doi: 10.2147/IJN.S234860. eCollection 2019.

9

Erratum: Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum].勘误：纳米载体介导的抗癌药物递送系统：概述与展望[勘误]。

Int J Nanomedicine. 2021 Jul 27;16:5099. doi: 10.2147/IJN.S330286. eCollection 2021.

10

Erratum: A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer [Corrigendum].勘误：一种用于增强近红外图像引导光热治疗胃癌的智能多功能纳米粒子 [更正]。

Int J Nanomedicine. 2021 May 3;16:3121-3123. doi: 10.2147/IJN.S317890. eCollection 2021.